D.S. v. HHS - MMR, thrombocytopenic purpura (2017)

Bernadette Dicianni and Michael Szilagyi, parents of D.S., a minor, filed a petition for compensation under the National Vaccine Injury Compensation Program on December 18, 2015. They alleged that D.S. suffered from thrombocytopenic purpura following his measles-mumps-rubella (MMR) vaccination on December 26, 2012.

The petition stated that the first symptoms of the condition appeared within the time period set forth in the Vaccine Injury Table, that D.S. experienced residual effects for more than six months, and that no unrelated factors or prior awards were responsible for the condition. The parties filed a joint stipulation agreeing that D.S. was entitled to compensation.

Chief Special Master Nora Beth Dorsey found the stipulation reasonable and adopted it as the decision of the Court. The award included a lump sum of $93,109.00 payable to the petitioners as guardians of D.S.'s estate and a lump sum of $1,891.00 for out-of-pocket expenses, payable to the petitioners in their individual capacity.

These amounts represent compensation for all damages available under the Vaccine Act. Edward M.

Kraus represented the petitioner, and Robert Paul Coleman, III represented the respondent.